LSBC and Illumina Adopt Stockholder Rights Plans | GenomeWeb

NEW YORK, May 4 – Large Scale Biology and Illumina both adopted stockholder rights plans Friday, in a preemptive effort to head off hostile takeover attempts, the companies said.

The actions follow similar moves by several other companies in the last several weeks, and are “usually a clue that things are getting too cheap in the markets,” said Franklin Berger, an analyst with JP Morgan H&Q in New York.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.